ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call
ICU Medical (Nasdaq: ICUI), a leading medical products manufacturer, has scheduled its second quarter 2025 earnings release and conference call. The company will release Q2 2025 results on Thursday, August 7, 2025, at 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET.
Investors can access the call via phone at (800) 267-6316 using conference ID "ICUMED" or through a webcast available on the company's website. The webcast will also be available for replay through ICU Medical's investor relations section at www.icumed.com.
ICU Medical (Nasdaq: ICUI), un produttore leader di dispositivi medici, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 e la conferenza telefonica. L'azienda renderà noti i risultati del Q2 2025 giovedì 7 agosto 2025 alle 16:00 ET, seguiti da una conferenza telefonica alle 16:30 ET.
Gli investitori potranno partecipare alla chiamata telefonando al numero (800) 267-6316 utilizzando l'ID conferenza "ICUMED" oppure tramite una trasmissione web disponibile sul sito aziendale. La registrazione della webcast sarà inoltre accessibile in replay nella sezione relazioni con gli investitori di ICU Medical all'indirizzo www.icumed.com.
ICU Medical (Nasdaq: ICUI), un fabricante líder de productos médicos, ha programado la publicación de resultados del segundo trimestre de 2025 y la llamada de conferencia. La compañía dará a conocer los resultados del Q2 2025 el jueves 7 de agosto de 2025 a las 4:00 p.m. ET, seguida por una llamada de conferencia a las 4:30 p.m. ET.
Los inversores pueden acceder a la llamada por teléfono al (800) 267-6316 usando el ID de conferencia "ICUMED" o a través de una transmisión web disponible en el sitio web de la compañía. La transmisión también estará disponible para reproducción en la sección de relaciones con inversores de ICU Medical en www.icumed.com.
ICU Medical (나스닥: ICUI)는 선도적인 의료 제품 제조업체로, 2025년 2분기 실적 발표 및 컨퍼런스 콜을 예정하고 있습니다. 회사는 2025년 8월 7일 목요일 오후 4시(동부시간)에 2분기 실적을 발표하며, 이어서 오후 4시 30분(동부시간)에 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 전화번호 (800) 267-6316으로 컨퍼런스 ID "ICUMED"를 사용해 통화에 참여할 수 있으며, 회사 웹사이트에서 제공되는 웹캐스트를 통해서도 접속할 수 있습니다. 웹캐스트는 ICU Medical 투자자 관계 섹션(www.icumed.com)에서 다시보기로도 제공됩니다.
ICU Medical (Nasdaq : ICUI), un fabricant de dispositifs médicaux de premier plan, a programmé la publication des résultats du deuxième trimestre 2025 et la conférence téléphonique. La société publiera les résultats du T2 2025 le jeudi 7 août 2025 à 16h00 ET, suivis d’une conférence téléphonique à 16h30 ET.
Les investisseurs peuvent accéder à l’appel par téléphone au (800) 267-6316 en utilisant l’ID de conférence "ICUMED" ou via un webcast disponible sur le site internet de la société. Le webcast sera également disponible en replay dans la section relations investisseurs de ICU Medical sur www.icumed.com.
ICU Medical (Nasdaq: ICUI), ein führender Hersteller von Medizinprodukten, hat die Veröffentlichung der Ergebnisse für das zweite Quartal 2025 und die Telefonkonferenz angekündigt. Das Unternehmen wird die Ergebnisse für Q2 2025 am Donnerstag, den 7. August 2025, um 16:00 Uhr ET veröffentlichen, gefolgt von einer Telefonkonferenz um 16:30 Uhr ET.
Investoren können über die Telefonnummer (800) 267-6316 mit der Konferenz-ID "ICUMED" an der Telefonkonferenz teilnehmen oder über einen Webcast auf der Unternehmenswebsite. Der Webcast wird auch als Aufzeichnung im Investor-Relations-Bereich von ICU Medical unter www.icumed.com verfügbar sein.
- None.
- None.
SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference call.
The Company will release its second quarter 2025 results on Thursday, August 7, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, August 7, 2025. The call can be accessed at (800) 267-6316, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
When is ICU Medical (ICUI) releasing its Q2 2025 earnings?
How can investors join ICU Medical's Q2 2025 earnings call?
What time is ICU Medical's Q2 2025 earnings conference call?
Will ICU Medical's Q2 2025 earnings call be available for replay?
